(Q49098244)

18 February 2018

title

Non-steroidal anti-inflammatory drug use and brain tumour risk: a case-control study within the Clinical Practice Research Datalink. (English)

1 reference

18 February 2018

0 references

7

1 reference

18 February 2018

author name string

F J Bannon

1

1 reference

18 February 2018

M A O'Rorke

2

1 reference

18 February 2018

L J Murray

3

1 reference

18 February 2018

C M Hughes

4

1 reference

18 February 2018

A T Gavin

5

1 reference

18 February 2018

S J Fleming

6

1 reference

18 February 2018

publication date

30 August 2013

1 reference

18 February 2018

published in

Cancer Causes & Control

1 reference

18 February 2018

volume

24

1 reference

18 February 2018

issue

11

1 reference

18 February 2018

page(s)

2027-2034

1 reference

18 February 2018

https://scigraph.springernature.com/pub.10.1007/s10552-013-0279-9

exact match

0 references

cites work

Brain tumours: incidence, survival, and aetiology

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Epidemiology and molecular pathology of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Epidemiology and etiology of meningioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Progesterone and estrogen receptors in meningiomas: prognostic considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Hormone therapy and brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Atopy and risk of brain tumors: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Clinicopathological evaluation of cyclooxygenase-2 expression in meningioma: immunohistochemical analysis of 76 cases of low and high-grade meningioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Inflammatory response and meningioma tumorigenesis and the effect of cyclooxygenase-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Expression of cyclooxygenase-2 and its correlation with vasogenic brain edema in human intracranial meningiomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Cyclooxygenase-2 expression in astrocytes and microglia in human oligodendroglioma and astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

The nonsteroidal anti-inflammatory drug celecoxib suppresses the growth and induces apoptosis of human glioblastoma cells via the NF-κB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Inhibition of human brain tumor cell growth by the anti-inflammatory drug, flurbiprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Celecoxib can induce vascular endothelial growth factor expression and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

National Cancer Institute workshop on chemopreventive properties of nonsteroidal anti-inflammatory drugs: role of COX-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Effect of aspirin and indomethacin on prostaglandin E2 synthesis in C6 glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Aspirin induces apoptosis through the blockade of IL-6-STAT3 signaling pathway in human glioblastoma A172 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Nonsteroidal anti-inflammatory drugs and glioma in the NIH-AARP Diet and Health Study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Use of low-dose aspirin and non-aspirin nonsteroidal anti-inflammatory drugs and risk of glioma: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Effects of antihistamine and anti-inflammatory medication use on risk of specific glioma histologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Case-control study of use of nonsteroidal antiinflammatory drugs and glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

HMG CoA reductase inhibitors, NSAIDs and risk of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Allergy and risk of glioma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Hormone replacement therapy and risk of meningioma in women: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Cancer recording and mortality in the General Practice Research Database and linked cancer registries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Using prescription claims data for drugs available over-the-counter (OTC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

Chronic statin therapy and the risk of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0279-9

10.1007/S10552-013-0279-9

21 January 2018

Identifiers

DOI

1 reference

18 February 2018

Dimensions Publication ID

0 references

1 reference

18 February 2018